Xbrane Biopharma AB had a revenue of 65.90M in the quarter ending Dec 31, 2024, with -1.36%. This bring the company's revenue in the last twelve months to 198.78M, Increased -0.50%. In the fiscal year ending Dec 31, 2024, Xbrane Biopharma AB had annual revenue of 198.70M with -16.77% growth.